Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
出版年份 2009 全文链接
标题
Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume 5, Issue 7, Pages 703-729
出版商
Informa Healthcare
发表日期
2009-05-15
DOI
10.1517/17425250902976854
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms
- (2009) Samuel Fanta et al. Pharmacogenetics and Genomics
- Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response
- (2009) Edward B. Mougey et al. Pharmacogenetics and Genomics
- Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinotecan-based chemotherapy
- (2008) Hiroshi Takane et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia
- (2008) Kazuma Kiyotani et al. CANCER SCIENCE
- Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans
- (2008) Y Yamasaki et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin
- (2008) S. Kitamura et al. DRUG METABOLISM AND DISPOSITION
- Different Effects ofSLCO1B1Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide
- (2008) Annikka Kalliokoski et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism
- (2008) Suttasinee Suwannakul et al. JOURNAL OF HUMAN GENETICS
- Increasing Systemic Exposure of Methotrexate by Active Efflux Mediated by Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3)
- (2008) Y. Kitamura et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
- (2008) T. Watanabe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- BCRP/ABCG2 in the Placenta: Expression, Function and Regulation
- (2008) Qingcheng Mao PHARMACEUTICAL RESEARCH
- No significant effect ofSLCO1B1polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone
- (2007) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy
- (2007) Silvia Sookoian et al. JOURNAL OF HEPATOLOGY
- Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer
- (2007) Ji-Youn Han et al. LUNG CANCER
- Global analysis of genetic variation in SLCO1B1
- (2007) Marja K Pasanen et al. PHARMACOGENOMICS
- Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy
- (2003) Miyuki Kimura et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started